<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>5(1)</volume><submitter>Chalkiadaki K</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>The polygenic nature of autism spectrum disorder (ASD) requires the identification of converging genetic pathways during early development to elucidate its complexity and varied manifestations.&lt;h4>Methods&lt;/h4>We developed a human cerebral organoid model from induced pluripotent stem cells with targeted genome editing to abolish protein expression of the &lt;i>CNTNAP2&lt;/i> ASD risk gene.&lt;h4>Results&lt;/h4>CNTNAP2&lt;sup>-/-&lt;/sup> cerebral organoids displayed accelerated cell cycle, ventricular zone disorganization, and increased cortical folding. Proteomic analysis revealed disruptions in glutamatergic/GABAergic (gamma-aminobutyric acidergic) synaptic pathways and neurodevelopment, and transcriptomic analysis revealed differentially expressed genes belonging to inhibitory neuron-re</pubmed_abstract><journal>Biological psychiatry global open science</journal><pagination>100413</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11699409</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>GABA/Glutamate Neuron Differentiation Imbalance and Increased AKT/mTOR Signaling in CNTNAP2&lt;sup>-/-&lt;/sup> Cerebral Organoids.</pubmed_title><pmcid>PMC11699409</pmcid><pubmed_authors>Chalkiadaki K</pubmed_authors><pubmed_authors>Moschovas D</pubmed_authors><pubmed_authors>Zafeiri M</pubmed_authors><pubmed_authors>Avgeropoulos A</pubmed_authors><pubmed_authors>Mason JO</pubmed_authors><pubmed_authors>Typou A</pubmed_authors><pubmed_authors>Theodoridou N</pubmed_authors><pubmed_authors>Samiotaki M</pubmed_authors><pubmed_authors>Voudouri G</pubmed_authors><pubmed_authors>Gkogkas CG</pubmed_authors><pubmed_authors>Statoulla E</pubmed_authors><pubmed_authors>Amvrosiadis T</pubmed_authors></additional><is_claimable>false</is_claimable><name>GABA/Glutamate Neuron Differentiation Imbalance and Increased AKT/mTOR Signaling in CNTNAP2&lt;sup>-/-&lt;/sup> Cerebral Organoids.</name><description>&lt;h4>Background&lt;/h4>The polygenic nature of autism spectrum disorder (ASD) requires the identification of converging genetic pathways during early development to elucidate its complexity and varied manifestations.&lt;h4>Methods&lt;/h4>We developed a human cerebral organoid model from induced pluripotent stem cells with targeted genome editing to abolish protein expression of the &lt;i>CNTNAP2&lt;/i> ASD risk gene.&lt;h4>Results&lt;/h4>CNTNAP2&lt;sup>-/-&lt;/sup> cerebral organoids displayed accelerated cell cycle, ventricular zone disorganization, and increased cortical folding. Proteomic analysis revealed disruptions in glutamatergic/GABAergic (gamma-aminobutyric acidergic) synaptic pathways and neurodevelopment, and transcriptomic analysis revealed differentially expressed genes belonging to inhibitory neuron-re</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Jan</publication><modification>2026-06-01T23:12:46.174Z</modification><creation>2026-05-23T03:08:04.582Z</creation></dates><accession>S-EPMC11699409</accession><cross_references><pubmed>39758604</pubmed><doi>10.1016/j.bpsgos.2024.100413</doi></cross_references></HashMap>